NeurotechMagProGet access
News & Press

Inspire V eliminates separate sensing lead — simplified single-lead surgery reduces procedure time and expands surgeon pool

JPM 2026 / Medical Device Network1/13/2026·01/13/26🌐 USA

Summary

Inspire Medical launched the Inspire V system with a key engineering advancement: the separate sensing lead required in prior Inspire generations has been eliminated. The Inspire V neurostimulator now integrates breathing detection directly into the main device without requiring a separate intercostal sensing lead. This reduces the Inspire procedure from a three-incision surgery (neurostimulator pocket, sensing lead, stimulation cuff) to a two-incision surgery, shortening OR time and reducing the learning curve for surgeons new to upper airway stimulation. Inspire Medical presented data at JPMorgan Healthcare Conference 2026 emphasizing Inspire V as a "growth engine" and detailed the coding clarification — CPT code 64582 with -52 modifier — for the simplified procedure.

Why it matters

Eliminating the sensing lead is the most significant surgical simplification in Inspire's history. Every incremental reduction in surgical complexity expands the surgeon pool that can offer HNS: the existing pool of ENTs and sleep surgeons who perform uvulopalatopharyngoplasty (UPPP) can now adopt Inspire V without dedicated HNS surgical training programs. A larger surgeon pool means more geographic access for the 30 million US OSA patients who need alternatives to CPAP.

#BCI#Neurostimulation#Sleep Tech#USA

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items — updated daily.

Start free trial
Already a member? Sign in